trial summary · NCT06882772
Butyric Acid Supplementation for Gut Improvement After Cardiac Surgery in Kids
Butyric Acid Supplementation for Gut Improvement After Cardiac Surgery in Kids, A Phase IIa Clinical Trial
Trial record from the TrialBase DB dataset, status RECRUITING, condition Congenital Heart Disease (CHD), sponsored by University of Nebraska. Facts below are exported values from the current release, not inferred or edited prose.
Summary
The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.
Butyric acid has been shown to promote gut health and improve the microbiome in multiple adult studies. In preliminary studies in older children with inflammatory bowel disease, butyric acid was shown to be safe. However, it's suitability for infants and young children with congenital heart disease (CHD) has yet to be determined. This study will examine butyric acid supplementation in infants and children, ages 1 month to 3 years, with CHD who require cardiac surgery with cardiopulmonary bypass. Study goals include determining the safety and tolerability of butyric acid supplementation before cardiac surgery, and to identify changes in gut microbial communities, metabolic profile, and genetic markers intestinal function. Also, the study seeks to establish a reduction in inflammation (inflammatory signaling) after cardiopulmonary bypass (CPB) in participants receiving butyric acid.
Source record: https://clinicaltrials.gov/study/NCT06882772
Facts
| registry id | NCT06882772 |
|---|---|
| primary registry | clinicaltrials-gov |
| recruitment status | RECRUITING |
| phase | PHASE1/PHASE2 |
| study type | INTERVENTIONAL |
| lead condition | Congenital Heart Disease (CHD) |
| sponsor | University of Nebraska |
| sponsor class | OTHER |
| enrollment | 105 |
| start date | 2026-11-01 |
| primary completion | 2029-06-30 |
| completion | 2029-12-31 |
| results posted | not reported |
Conditions
- Congenital Heart Disease (CHD)
Interventions
- 2 mL SunButyrate-TG
- Placebo
- 4 mL SunButyrate-TG
Countries
- United States
Intervention types: DRUG
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access; credited toward the licence.